Liang Zhao

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 26

Top Topics

Machine Learning

Radical Prostatectomy

Top Venues

CPT: pharmacometrics & systems pharmacology

Clinical pharmacology and therapeutics

The AAPS journal

Journal of pharmacokinetics and pharmacodynamics

This page only lists publications with an associated author ORCID identifier.

Publications

Lanyan Fang, Yuqing Gong, Andrew C Hooker, Viera Lukacova, Amin Rostami-Hodjegan, Mark Sale, Stella Grosser, Rebeka Jereb, Rada Savic, Carl Peck, Liang Zhao
The Role of Model Master Files for Sharing, Acceptance, and Communication with FDA. The AAPS journal 26 (2) (2024)
Henrik B Nyberg, Xiaomei Chen, Mark Donnelly, Lanyan Fang, Liang Zhao, Mats O Karlson, Andrew C Hooker
Evaluation of model-integrated evidence approaches for pharmacokinetic bioequivalence studies using model averaging methods. CPT: pharmacometrics & systems pharmacology (2024)
Liang Zhao, Kathleen M Giacomini, Piet H van der Graaf
Progress in Clinical Pharmacology in China: A Randomized Controlled Study to Advance Genotype-Guided Precision Medicine. Clinical pharmacology and therapeutics 115 (2) (2024)
Liang Zhao, Kathleen M Giacomini, Piet H van der Graaf
Progress in Clinical Pharmacology in China: A Randomized Controlled Study to Advance Genotype-Guided Precision Medicine. Clinical pharmacology and therapeutics 115 (2) (2024)
Lanyan Fang, Yuqing Gong, Andrew C Hooker, Viera Lukacova, Amin Rostami-Hodjegan, Mark Sale, Stella Grosser, Rebeka Jereb, Rada Savic, Carl Peck, Liang Zhao
The Role of Model Master Files for Sharing, Acceptance, and Communication with FDA. The AAPS journal 26 (2) (2024)
Lanyan Fang, Yuqing Gong, Andrew C Hooker, Viera Lukacova, Amin Rostami-Hodjegan, Mark Sale, Stella Grosser, Rebeka Jereb, Rada Savic, Carl Peck, Liang Zhao
The Role of Model Master Files for Sharing, Acceptance, and Communication with FDA. The AAPS journal 26 (2) (2024)
Liang Zhao, Kathleen M Giacomini, Piet H van der Graaf
Progress in Clinical Pharmacology in China: A Randomized Controlled Study to Advance Genotype-Guided Precision Medicine. Clinical pharmacology and therapeutics 115 (2) (2024)
Lanyan Fang, Yuqing Gong, Andrew C Hooker, Viera Lukacova, Amin Rostami-Hodjegan, Mark Sale, Stella Grosser, Rebeka Jereb, Rada Savic, Carl Peck, Liang Zhao
The Role of Model Master Files for Sharing, Acceptance, and Communication with FDA. The AAPS journal 26 (2) (2024)
Xinnong Li, Mark Sale, Keith Nieforth, James Craig, Fenggong Wang, David Solit, Kairui Feng, Meng Hu, Robert R Bies, Liang Zhao
pyDarwin machine learning algorithms application and comparison in nonlinear mixed-effect model selection and optimization. Journal of pharmacokinetics and pharmacodynamics (2024)
Xiaomei Chen, Henrik B Nyberg, Mark Donnelly, Liang Zhao, Lanyan Fang, Mats O Karlson, Andrew C Hooker
Development and comparison of model-integrated evidence approaches for bioequivalence studies with pharmacokinetic end points. CPT: pharmacometrics & systems pharmacology (2024)
Andrew Babiskin, Fang Wu, Youssef Mousa, Ming-Liang Tan, Eleftheria Tsakalozou, Ross L Walenga, Miyoung Yoon, Sam G Raney, James E Polli, Anna Schwendeman, Vishalakshi Krishnan, Lanyan Fang, Liang Zhao
Regulatory utility of mechanistic modeling to support alternative bioequivalence approaches: A workshop overview. CPT: pharmacometrics & systems pharmacology (2023)
Ming-Liang Tan, Zongming Gao, Andrew Babiskin, Myong-Jin Kim, Lanyan Fang, Lei Zhang, Liang Zhao
Use of physiologically-based pharmacokinetic modeling to understand the effect of omeprazole administration on the pharmacokinetics of oral extended-release nifedipine. CPT: pharmacometrics & systems pharmacology 13 (2) (2023)
Coralie Tardivon, Florence Loingeville, Mark Donnelly, Kairui Feng, Wanjie Sun, Guoying Sun, Stella Grosser, Liang Zhao, Lanyan Fang, France Mentré, Julie Bertrand
Evaluation of model-based bioequivalence approach for single sample pharmacokinetic studies. CPT: pharmacometrics & systems pharmacology (2023)
Liang Zhao, Dajun Sun, Ming-Liang Tan, Mingjiang Xu, Minori Kinjo, Kairui Feng, Hezhen Wang, Robert Lionberger
Effect of Omeprazole Administration on the Pharmacokinetics of Oral Extended-release Nifedipine in Healthy Subjects. Clinical pharmacology and therapeutics (2023)
Yuqing Gong, Peijue Zhang, Miyoung Yoon, Hao Zhu, Ameya Kohojkar, Andrew C Hooker, Murray P Ducharme, Jogarao V S Gobburu, Géraldine Cellière, Parmesh Gajjar, Bing V Li, Raja Velagapudi, Yu Chung Tsang, Anna Schwendeman, James E Polli, Lanyan Fang, Robert Lionberger, Liang Zhao
Establishing the Suitability of Model-Integrated Evidence to Demonstrate Bioequivalence for Long-Acting Injectable and Implantable Drug Products: Summary of Workshop. CPT: pharmacometrics & systems pharmacology (2023)
Xinnong Li, Mark Sale, Keith Nieforth, Kristin L Bigos, James Craig, Fenggong Wang, Kairui Feng, Meng Hu, Robert R Bies, Liang Zhao
pyDarwin: A Machine Learning Enhanced Automated Nonlinear Mixed-effect Model Selection Toolbox. Clinical pharmacology and therapeutics (2023)
Ming-Liang Tan, Zongming Gao, Andrew Babiskin, Myong-Jin Kim, Lanyan Fang, Lei Zhang, Liang Zhao
Use of physiologically-based pharmacokinetic modeling to understand the effect of omeprazole administration on the pharmacokinetics of oral extended-release nifedipine. CPT: pharmacometrics & systems pharmacology 13 (2) (2023)
Miyoung Yoon, Andrew Babiskin, Meng Hu, Fang Wu, Sam G Raney, Lanyan Fang, Liang Zhao
Increasing impact of quantitative methods and modeling in establishment of bioequivalence and characterization of drug delivery. CPT: pharmacometrics & systems pharmacology (2023)
Ming-Liang Tan, Zongming Gao, Andrew Babiskin, Myong-Jin Kim, Lanyan Fang, Lei Zhang, Liang Zhao
Use of physiologically-based pharmacokinetic modeling to understand the effect of omeprazole administration on the pharmacokinetics of oral extended-release nifedipine. CPT: pharmacometrics & systems pharmacology 13 (2) (2023)
Ming-Liang Tan, Zongming Gao, Andrew Babiskin, Myong-Jin Kim, Lanyan Fang, Lei Zhang, Liang Zhao
Use of physiologically-based pharmacokinetic modeling to understand the effect of omeprazole administration on the pharmacokinetics of oral extended-release nifedipine. CPT: pharmacometrics & systems pharmacology 13 (2) (2023)
Vaibhav Kumar, Fenggong Wang, Meng Hu, Paul Kluetz, Liang Zhao
Landscape Analysis of Generic Availability for Oncologic Drugs. Therapeutic innovation & regulatory science (2023)
Yuqing Gong, Peijue Zhang, Miyoung Yoon, Hao Zhu, Ameya Kohojkar, Andrew C Hooker, Murray P Ducharme, Jogarao V S Gobburu, Géraldine Cellière, Parmesh Gajjar, Bing V Li, Raja Velagapudi, Yu Chung Tsang, Anna Schwendeman, James E Polli, Lanyan Fang, Robert Lionberger, Liang Zhao
Establishing the suitability of model-integrated evidence to demonstrate bioequivalence for long-acting injectable and implantable drug products: Summary of workshop. CPT: pharmacometrics & systems pharmacology (2023)
Ming-Liang Tan, Zongming Gao, Andrew Babiskin, Myong-Jin Kim, Lanyan Fang, Lei Zhang, Liang Zhao
Use of physiologically-based pharmacokinetic modeling to understand the effect of omeprazole administration on the pharmacokinetics of oral extended-release nifedipine. CPT: pharmacometrics & systems pharmacology (2023)
Andrew Babiskin, Fang Wu, Youssef Mousa, Ming-Liang Tan, Eleftheria Tsakalozou, Ross L Walenga, Miyoung Yoon, Sam G Raney, James E Polli, Anna Schwendeman, Vishalakshi Krishnan, Lanyan Fang, Liang Zhao
Regulatory Utility of Mechanistic Modeling to Support Alternative Bioequivalence Approaches: A Workshop Overview. CPT: pharmacometrics & systems pharmacology (2023)
Peijue Zhang, Kairui Feng, Yuqing Gong, Jieon Lee, Sara Lomonaco, Liang Zhao
Usage of Compartmental Models in Predicting COVID-19 Outbreaks. The AAPS journal 24 (5) (2022)
Xiajing Gong, Meng Hu, Jinzhong Liu, Geoffrey Kim, James Xu, Amy McKee, Todd Palmby, R Angelo de Claro, Liang Zhao
Decoding kinase-adverse event associations for small molecule kinase inhibitors. Nature communications 13 (1) (2022)